Core Insights - Marex Group plc (MRX) is set to report its third-quarter 2025 results, with expectations of year-over-year increases in earnings and revenues [1][10] - The company has a strong earnings surprise history, having exceeded the Zacks Consensus Estimate in the last four quarters with an average beat of 11.58% [2] Q3 Developments - During Q3, Marex Group executed its growth strategy by expanding into new geographies and product capabilities, including the acquisition of Agrinvest in Brazil and Hamilton Court Group for enhanced FX capabilities in EMEA [3][4] - A strategic partnership with FalconX was established to provide clients access to digital asset derivatives [5] Market Conditions - Strong trading volumes and client activity were noted in Q3, driven by a global risk-on sentiment and dovish central bank stances, with equity markets benefiting from moderating inflation and easing geopolitical tensions [6] - Despite a decline in exchange volumes at CME and ICE by over 15%, Marex Group is expected to report solid financial results, supported by its diversified franchise and recent acquisitions [7] Financial Performance Estimates - Average clearing client balances increased by 4% sequentially to $13.3 billion, with clearing revenues estimated at $126 million, an 8% increase year-over-year [8] - Agency and execution revenues are projected to rise by 40.6% to $239.6 million, while market making revenues are expected to grow by 5% to $54.6 million [9] - Preliminary results indicate a profit before tax of up to $101 million and a return on equity (ROE) near 27% [10][12] Cost and Investment Insights - Total operating expenses are anticipated to be elevated as the company invests in enhancing platform capabilities, product innovation, and regulatory compliance [11] Earnings and Sales Estimates - The Zacks Consensus Estimate for earnings is unchanged at 92 cents per share, reflecting a 21.1% increase from the previous year, while sales are estimated at $480 million, indicating a 22.7% jump [15] - Preliminary revenue expectations range between $475 million and $485 million, up from $391 million in the prior year [16]

Group 1: Earnings Performance - Bentley Systems reported quarterly earnings of $0.27 per share, matching the Zacks Consensus Estimate, and an increase from $0.24 per share a year ago [1] - The company posted revenues of $375.55 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 2.59% and up from $335.17 million year-over-year [2] - Over the last four quarters, Bentley Systems has surpassed consensus EPS estimates two times and revenue estimates three times [2][1] Group 2: Stock Performance and Outlook - Bentley Systems shares have increased approximately 4.8% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The company's earnings outlook will be crucial for future stock movements, with current consensus EPS estimates at $0.28 for the coming quarter and $1.21 for the current fiscal year [7] - The estimate revisions trend for Bentley Systems was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Group 3: Industry Context - The Internet - Software industry, to which Bentley Systems belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Clover Health Investments, Corp. reported break-even quarterly earnings per share, compared to a loss of $0.02 per share a year ago, resulting in an earnings surprise of -100.00% [1] - The company posted revenues of $496.65 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.47%, and showing a year-over-year revenue increase from $330.99 million [2] - Clover Health shares have increased approximately 16.8% since the beginning of the year, slightly outperforming the S&P 500's gain of 16.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is breakeven on revenues of $486.6 million, while for the current fiscal year, the estimate is $0.10 on revenues of $1.9 billion [7] - The estimate revisions trend for Clover Health was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical Info Systems industry, to which Clover Health belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Ovid Therapeutics, driven by higher revenues, but actual results compared to estimates will significantly influence the stock price [1][2]. Earnings Expectations - Ovid Therapeutics is expected to report a quarterly loss of $0.15 per share, reflecting a year-over-year change of +25% [3]. - Revenues are projected to be $0.34 million, representing a 100% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 5.26% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Ovid is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -4.50%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, with positive readings being more reliable [9][10]. - Ovid's current Zacks Rank is 3, which complicates predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Ovid was expected to post a loss of $0.16 per share but actually reported a loss of -$0.06, achieving a surprise of +62.50% [13]. - Over the past four quarters, Ovid has beaten consensus EPS estimates two times [14]. Industry Context - Avidity Biosciences, a peer in the Zacks Medical - Biomedical and Genetics industry, is expected to report a loss of $1.05 per share, indicating a year-over-year change of -61.5% [18]. - Avidity's revenue is expected to be $2.5 million, up 6.8% from the previous year, but it also has a negative Earnings ESP of -9.35% [19][20].

Core Viewpoint - Evergy, Inc. (EVRG) is expected to report its third-quarter 2025 results on November 6, with a prior earnings surprise of 7.89% in the last quarter [1] Factors Impacting Q3 Earnings - Ongoing investments in infrastructure and technology are likely to support Evergy's third-quarter earnings, addressing increasing customer demand [2] - Economic development within service areas is anticipated to lead to stronger demand, particularly from data centers [2] - The rise in demand from residential, commercial, and industrial customers is expected to positively influence earnings, although higher operating and maintenance expenses may negatively impact the bottom line [3] Q3 Expectations - The Zacks Consensus Estimate for earnings is projected at $2.14 per share, reflecting a year-over-year increase of 5.9% [4] - Revenue estimates stand at $1.87 billion, indicating a 3.4% increase from the previous year [4] Earnings Prediction Model - The current Earnings ESP for Evergy is 0.00%, indicating that the model does not predict an earnings beat this time [5] - Evergy holds a Zacks Rank of 2 (Buy), which typically suggests a favorable outlook [6] Comparable Stocks - Atmos Energy Corporation (ATO) is expected to report its fourth-quarter fiscal 2025 results on November 5, with an Earnings ESP of +4.85% and a Zacks Rank of 2 [7] - Duke Energy (DUK) is scheduled to report its third-quarter 2025 results on November 7, with an Earnings ESP of +1.63% and a Zacks Rank of 2 [10] - New Jersey Resources Corporation (NJR) is set to report its fourth-quarter fiscal 2025 results on November 19, with an Earnings ESP of +8.51% and a Zacks Rank of 3 [11]

Global Payments (GPN) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $3.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.93%. A quarter ago, it was expected that this electronics payment processing company would post earnings of $3.03 per share when it actually produced earnings of $3.1, delivering a surprise of +2.31%.Over the las ...

Core Insights - Eaton reported quarterly earnings of $3.07 per share, exceeding the Zacks Consensus Estimate of $3.06 per share, and up from $2.84 per share a year ago, representing an earnings surprise of +0.33% [1] - The company posted revenues of $6.99 billion for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 0.98%, but an increase from $6.35 billion year-over-year [2] - Eaton's stock has gained approximately 16.5% since the beginning of the year, matching the S&P 500's performance [3] Earnings Outlook - The future performance of Eaton's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $3.36 on revenues of $7.11 billion, and for the current fiscal year, it is $12.08 on revenues of $27.57 billion [7] Industry Context - The Manufacturing - Electronics industry, to which Eaton belongs, is currently ranked in the top 17% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]

Market Performance - Global indices mostly rose last week, with MSCI Global up by 0.6%, MSCI Developed Markets up by 0.6%, and MSCI Emerging Markets up by 0.9% [7][31] - Among developed markets, Nikkei 225 had the strongest performance with a gain of 6.3%, while the Australian S&P 200 was the weakest, down by 1.5% [7][31] - In emerging markets, the Mexican MXX index performed best with a rise of 2.7%, while the Hang Seng Index was the worst performer, down by 1.0% [7][31] Trading Sentiment - Global trading volume generally improved, with North American holdings index reaching a historical high [21] - The trading volume for major indices such as the Shanghai Composite, S&P 500, and Nikkei 225 saw fluctuations, with the Shanghai Composite and Hang Seng Index experiencing declines [21][27] - Investor sentiment in Hong Kong improved but remained at a historical low, while sentiment in the US was at a historical high [21][28] Fundamental Analysis - Earnings expectations for US tech and consumer discretionary sectors were significantly revised upwards during the earnings season [63] - The S&P 500's 2025 EPS earnings expectation was adjusted from 269 to 270, with the technology sector seeing the largest upward revision of +2.4 [63][64] - In the Hong Kong market, the Hang Seng Index's 2025 EPS earnings expectation was revised from 2062 to 2066, with the materials sector seeing the largest increase [63][64] Economic Outlook - Major market sentiment indicators showed a rebound, with the Citigroup Economic Surprise Index for the US rising due to the Fed's rate cut and improved earnings from tech giants [7][63] - The European Economic Surprise Index also increased, supported by stable ECB rates and a temporary easing of political tensions in France [7][63] - The Chinese Economic Surprise Index rose, bolstered by positive Q3 data and favorable policies [7][63] Capital Flows - The Federal Reserve cut rates as expected, but there were hawkish signals regarding future cuts [52] - As of October 31, market expectations indicated the Fed would cut rates 0.68 times by year-end, a decrease from the previous week [52][53] - Global liquidity trends showed significant inflows into the US, China, India, Japan, and South Korea, with Hong Kong seeing substantial inflows through the Stock Connect program [58][62]

Core Viewpoint - W.W. Grainger, Inc. is experiencing a downward trend in stock price targets despite reporting a revenue increase, indicating a cautious outlook from analysts regarding the company's future earnings potential [2][3][6] Financial Performance - GWW reported a 5.6% increase in second-quarter revenue, demonstrating a strong market position and effective business strategies [4][6] - However, the company's earnings for the second quarter fell short of expectations, prompting analysts to adjust their forecasts [4] Analyst Sentiment - The consensus price target for GWW has decreased from $1,031 last year to $963 last month, with Wells Fargo setting a notably lower target of $475 [2][6] - JPMorgan revised its price target for GWW from $1,125 to $1,035 while maintaining a Neutral rating on the shares, reflecting a cautious outlook on the company's future earnings potential [3][6]

Core Viewpoint - Midland States Bancorp reported quarterly earnings of $0.24 per share, significantly missing the Zacks Consensus Estimate of $0.61 per share, and down from $0.74 per share a year ago, indicating a -60.66% earnings surprise [1][2] Financial Performance - The company posted revenues of $81.13 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.73%, and up from $74.29 million year-over-year [2] - Over the last four quarters, Midland States Bancorp has exceeded consensus revenue estimates four times [2] Stock Performance - Shares of Midland States Bancorp have declined approximately 33.8% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.67 on revenues of $80.45 million, and for the current fiscal year, it is $2.17 on revenues of $318.9 million [7] - The trend of estimate revisions for Midland States Bancorp was mixed prior to the earnings release, which may change following the recent report [6] Industry Context - The Zacks Industry Rank for Banks - Northeast is currently in the top 14% of over 250 Zacks industries, suggesting a favorable outlook for the sector [8]